| Literature DB >> 26498476 |
Constantina Aggeli1, Stauroula Lagoudakou2, Ioannis Felekos2, Vasiliki Panagopoulou2, Stellios Kastellanos2, Konstantinos Toutouzas2, George Roussakis2, Dimitris Tousoulis2.
Abstract
BACKGROUND: Two-dimensional speckle tracking provides valuable information for regional wall motion abnormalities. The purpose of this study was to determine the diagnostic value of left ventricular longitudinal strain and torsion to diagnose coronary artery disease during dobutamine stress echocardiography.Entities:
Mesh:
Year: 2015 PMID: 26498476 PMCID: PMC4619392 DOI: 10.1186/s12947-015-0038-z
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Fig. 1A patient with LAD disease (a) and a normal patient (b) are illustrated (apical 4-chamber view and bull’s-eye) at peak stress
Patient demographics
| Baseline characteristics | Total ( | CAD(+) ( | CAD (−) ( |
|
|---|---|---|---|---|
| Male, | 72 (72 %) | 54 (75 %) | 18 (25 %) | 0.006 |
| Age (year) | 60.8 ± 10.7 | 63.2 ± 10.3 | 55.8 ± 9.9 | 0.001 |
| Hypertension, | 59 (59 %) | 44 (65.7 %) | 15(45.5 %) | 0.05 |
| Diabetes, | 23 (23 %) | 21 (31.3 %) | 2 (6.1 %) | 0.05 |
| Dyslipidaemia, | 69 (69 %) | 52 (77.6 %) | 17 (51.5 %) | 0.08 |
| Smoking, | 30 (30 %) | 21(31.3 %) | 9 (27.3 %) | 0.7 |
| Family Hx for CAD, | 31 (31 %) | 18 (26.9 %) | 13 (39.4 %) | 0.2 |
| LV ejection fraction, (%) | 55 ± 5.4 | 53.4 ± 5.3 | 58.2 ± 4.1 | 0.6 |
| WMSI rest | 1.06 ± 0.99 | 1.08 ± 0.1 | 1.02 ± 0.5 | <0.05 |
| WMSI stress | 1.20 ± 0.2 | 1.28 ± 0.18 | 1.02 ± 0.07 | <0.001 |
| WMSIΔ | 0.13 ± 0.19 | 0.2 ± 0.19 | 0.003 ± 0.08 | <0.001 |
| Coronary artery disease, | 67 (67 %) | |||
| LAD | 38 (38 %) | |||
| LCX | 29 (29 %) | |||
| RCA | 28 (28 %) | |||
| 1-vessel disease | 46 (46 %) | |||
| 2-vessel disease | 14 (14 %) | |||
| 3-vessel disease | 7 (7 %) |
Patient hemodynamics at rest and stress
| Hemodynamics | Rest | Stress |
|---|---|---|
| Systolic BP (mmHg) | 138 ± 15 | 167 ± 10 |
| Diastolic BP (mmHg) | 82 ± 8 | 89 ± 6 |
| HR (bpm) | 73 ± 7 | 135 ± 12 |
Speckle tracking measurements
| CAD (+) | CAD (−) |
| |
|---|---|---|---|
| Global longitudinal peak systolic strain (%) | |||
| Rest | −21.16 ± 3.32 | −21.59 ± 2.33 | 0.46 |
| Peak dose | −18.95 ± 4.34 | −23.16 ± 3.30 | <0.001 |
| Delta | −2.23 ± 3.36 | 1.56 ± 3.15 | <0.001 |
| Global torsion (o) | |||
| Rest | 21.77 ± 5.47 | 21.27 ± 7.61 | 0.790 |
| Peak dose | 19.65 ± 13.57 | 30.76 ± 12.03 | 0.002 |
| Delta | −2.42 ± 13.96 | 9.50 ± 10.46 | 0.001 |
| Base rotation (o) | |||
| Rest | −9.28 ± 2.87 | −9.74 ± 2.98 | 0.560 |
| Peak dose | −8.76 ± 5.28 | −12.60 ± 4.63 | 0.006 |
| Delta | −0.52 ± 6.24 | 2.84 ± 3.61 | 0.012 |
| Apex rotation (o) | |||
| Rest | 14.03 ± 4.02 | 14.57 ± 5.62 | 0.692 |
| Peak dose | 13.13 ± 9.29 | 21.39 ± 8.84 | 0.001 |
| Delta | −0.90 ± 8.88 | 6.76 ± 8.69 | 0.002 |
Fig. 2Torsion curves, along with apical and base rotations are depicted at rest and peak stress in a normal patient and a patient with CAD
Fig. 3Roc Curves regarding (a) wall-motion score index delta (WMSId), (b) Global Longitudinal strain (GLS) delta and Torsion delta, (c) Global Longitudinal strain delta for LAD and (d) posterior circulation disease and (e) Torsion delta for anterior and (f) posterior circulation disease
Comparison of AUC
| AUC | SE | 95 % CI | |
|---|---|---|---|
| GLSΔ | 0,80 | 0,0711 | 0,615 to 0,859 |
| ΤorsionΔ | 0,76 | 0,0739 | 0,601 to 0,849 |
| WMSIΔ | 0,84 | 0,0618 | 0,668 to 0,896 |
| Torsion and GLS combined | 0,77 | 0,0737 | 0,619 to 0,862 |
| GLSΔ vs WMSIΔ | |||
| Significance level |
| ||
| ΤorsionΔ vs WMSIΔ | |||
| Significance level |
| ||
| WMSIΔ vs Torsion and GLS combined | |||
| Significance level |
| ||
GLS (%) parameters per vessel
| LAD disease (+) | LAD disease (−) |
| |
|---|---|---|---|
| Rest | −21.86 ± 3.09 | −23.20 ± 2.87 | 0.03 |
| Peak dose | −16.38 ± 5.76 | −24.96 ± 4.42 | <0.001 |
| Delta | −5.46 ± 5.27 | 1.76 ± 3.77 | <0.001 |
| LCX disease (+) | LCX disease (−) | ||
| Rest | −19.80 ± 3.16 | −21.70 ± 2.88 | 0.01 |
| Peak dose | −16.13 ± 4.53 | −23.43 ± 3.69 | <0.001 |
| Delta | −3.59 ± 4.91 | 1.51 ± 4.14 | <0.001 |
| RCA disease (+) | RCA disease (−) | ||
| Rest | −18.73 ± 3.052 | −20.23 ± 2.87 | 0.04 |
| Peak dose | −15.69 ± 5.96 | −22.11 ± 4.21 | <0.001 |
| Delta | −3.47 ± 5.22 | 1.65 ± 4.17 | <0.001 |
| LCX-RCA disease (+) | LCX-RCA disease (−) | ||
| Rest | −19.28 ± 2.10 | −20.29 ± 2.33 | 0.03 |
| Peak dose | −16.43 ± 5.30 | −22.42 ± 3.95 | <0.001 |
| Delta | −2.83 ± 5.11 | 2.18 ± 3.95 | <0.001 |